PureTech News

Press Releases
ALL >
Press Release - 2026-04-29
Other
PureTech Announces Annual Results for Year Ended December 31, 2025
Press Release - 2026-04-29
Other
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
Press Release - 2026-04-27
Seaport
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
Publications
ALL >
Publications 2026-04-02
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
Publications 2026-03-25
An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans
Publications 2025-05-08
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study

@PureTechH